Systematic review of cardiovascular disease in women: assessing the risk

Linda Worrall-Carter1, Chantal Ski, Elizabeth Scruth

  • 1St Vincent's/ACU Centre for Nursing Research, Australian Catholic University, 486 Albert Street, Melbourne, Australia. linda.worrall-carter@acu.edu.au

Nursing & Health Sciences
|November 11, 2011
PubMed

Insights

Cardiovascular disease (CVD) affects women differently, often presenting later with more comorbidities and atypical symptoms. Recognizing these sex differences is crucial for improving diagnosis and outcomes in female patients.

Area of Science:

  • Medical research
  • Cardiology
  • Women's health

Background:

  • Cardiovascular disease (CVD) is the leading cause of mortality for women globally.
  • Identifying sex-specific risk factors and increasing awareness are vital for reducing CVD burden in women.
  • Current understanding and clinical practice often overlook crucial gender-based differences in CVD presentation and progression.

Purpose of the Study:

  • To systematically review and examine the cardiovascular disease risk factors in women.
  • To highlight the sex differences in CVD presentation, risk, and diagnosis.
  • To emphasize the need for sex-specific considerations in research and clinical practice for improved female patient outcomes.

Main Methods:

  • A systematic literature search was conducted across major health databases.
  • Search terms included "cardiovascular disease" AND "women" OR "gender".
  • A total of 58 relevant articles were reviewed, supplemented by manual reference identification.

Main Results:

  • Cardiovascular disease typically manifests approximately 10 years later in women than in men.
  • Women often present with more comorbidities by the time of CVD diagnosis, increasing their risk.
  • Atypical symptoms in women can lead to diagnostic delays and misdiagnosis, complicating disease management.

Conclusions:

  • Increased awareness of sex differentiation in CVD risk factors and symptom presentation is evident.
  • Sex-specific aspects of CVD require more intensive consideration in both research and clinical practice.
  • Tailoring approaches based on sex differences is essential for enhancing clinical outcomes for female cardiovascular disease patients.

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Assessment of the Cardiovascular System II: Inspection01:29

Assessment of the Cardiovascular System II: Inspection

Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...